Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [156]
elearning [19]
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer
Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas...
ASCO GU 2019: Updates on non-metastatic castration-resistant prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Nicholas Mottet )
15 Feb 2019
Updates on metastatic bladder cancer from ASCO GU 2019
Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA
Updates on metastatic bladder cancer from ASCO GU 2019 ( Prof Arlene Siefker-Radtke - MD Anderson Cancer Center, Houston, USA )
15 Feb 2019
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell...
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
ASCO GU 2019 renal highlights ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
14 Feb 2019
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma
Prof Brian Rini - Cleveland Clinic, Cleveland, USA
Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma ( Prof Brian Rini - Cleveland Clinic, Cleveland, USA )
14 Feb 2019
Sacituzumab govitecan in patients with previously treated metastatic urothelial...
Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
Sacituzumab govitecan in patients with previously treated metastatic urothelial cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
14 Feb 2019
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer
Dr Arjun Balar - NYU Langone Health, New York City, USA
Updates from KEYNOTE 57: Pembrolizumab for patients with bladder cancer ( Dr Arjun Balar - NYU Langone Health, New York City, USA )
14 Feb 2019
BGICC 2019
BGICC 2019 ( )
28 Jan 2019
When to increase and decrease burden of treatment for breast cancer patients
Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy
When to increase and decrease burden of treatment for breast cancer patients ( Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy )
28 Jan 2019
APT for HER2 breast cancer patients with small tumours
Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
APT for HER2 breast cancer patients with small tumours ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )
28 Jan 2019
Nivolumab in combination with CIMAvax-EGF for lung cancer
Dr Grace Dy - Roswell Park Cancer Institute, USA
Nivolumab in combination with CIMAvax-EGF for lung cancer ( Dr Grace Dy - Roswell Park Cancer Institute, USA )
4 Jan 2019
Bispecific CD19/22 CAR therapy in children and young adults with ALL
Dr Liora M Schultz - Stanford University, Palo Alto, USA
Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )
17 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation